Received Jan 5, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | X5FN4 | — |
partial administration of second dose of Shingrix; just ran down the side of their arm; just ran down the side of their arm; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number X5FN4, expiry date 17-JUN-2027) for prophylaxis. On 02-JAN-2026, the patient received the 2nd dose of Shingrix. On 02-JAN-2026, an unknown time after receiving Shingrix, the patient experienced incomplete dose administered (Verbatim: partial administration of second dose of Shingrix), exposure via skin contact (Verbatim: just ran down the side of their arm) and inadvertent exposure to vaccine (Verbatim: just ran down the side of their arm). The outcome of the incomplete dose administered, exposure via skin contact and inadvertent exposure to vaccine were not applicable. Additional Information: GSK Receipt Date: 02-JAN-2026 Pharmacist reported the partial administration of the second dose of Shingrix to a patient, they had a patient that was coming in for the second dose. Also stated that they did not know if the syringe was like loose or if it was defective, but when injecting the medication some of it did not go into the arm, just ran down the side of their arm. Reporter did not know if the patient got the complete dose, but stated that they did get at least some. Reporter did not know how much of the dose the patient received, but they stated it was a partial dose. No further details were provided.